Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.

Molecular therapy : the journal of the American Society of Gene Therapy - 1 Apr 2001

Yamada K, Olsen J C, Patel M, Rao K W, Walsh C E

Abstract excerpt

Lentiviral vectors transduce nondividing hematopoietic cells more efficiently than other currently available vector systems. Here we report the results of human hematopoietic cell gene transfer using lentiviral vectors based upon human immunodeficiency virus (HIV-1) and equine infectious anemia v...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fanconi Anemia
Share to Fanconi Anemia Complementation Group Proteins
Share to Gene Transfer Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cells

Share to Infectious Anemia Virus, Equine

Share to Lentivirus

Share to Mitomycin

Share to Transgenes

Source

Identifiers

PMID: 11319908
DOI: 10.1006/mthe.2001.0287

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11319908-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.PMID 11319908Read ↗

Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.Semantic proximity Read ↗

Phenotype correction of Fanconi anemia group A hematopoietic stem cells using lentiviral vector.Semantic proximity Read ↗

Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer.Semantic proximity Read ↗

Advances in Gene Therapy for Fanconi Anemia.Semantic proximity Read ↗

Stem Cell Gene Therapy for Fanconi Anemia: Report from the 1st International Fanconi Anemia Gene Therapy Working Group MeetingSemantic proximity Read ↗

Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector.Semantic proximity Read ↗

Gene transfer for the eventual treatment of Fanconi's anemia.Semantic proximity Read ↗

Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells.Semantic proximity Read ↗

Clinical use of lentiviral vectorsSemantic proximity Read ↗

Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.Semantic proximity Read ↗

Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.Semantic proximity Read ↗

Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.